AusPAR: Nivolumab
Australian Public Assessment Report
Device/Product Name
Opdivo
Active ingredients
Nivolumab
AusPAR Date
Published
Submission Number
PM-2017-03888-1-4
Submission Type
Major variation – new indication
Decision
Rejected